Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 -22.13%
March 31, 2026 -17.16%
December 31, 2025 -6.47%
September 30, 2025 -15.18%
June 30, 2025 -32.87%
March 31, 2025 -44.24%
December 31, 2024 -32.76%
September 30, 2024 -41.12%
June 30, 2024 -54.21%
March 31, 2024 -74.09%
December 31, 2023 -65.64%
September 30, 2023 -39.04%
June 30, 2023 -7.51%
March 31, 2023 -29.09%
December 31, 2022 -48.09%
September 30, 2022 -63.58%
June 30, 2022 -52.95%
March 31, 2022 -47.77%
December 31, 2021 -11.95%
September 30, 2021 -35.79%
June 30, 2021 -36.09%
March 31, 2021 -56.78%
December 31, 2020 -13.35%
September 30, 2020 -53.70%
June 30, 2020 -109.2%
Date Value
March 31, 2020 -39.04%
December 31, 2019 -64.82%
September 30, 2019 -57.69%
June 30, 2019 -64.60%
March 31, 2019 -99.63%
December 31, 2018 -56.14%
September 30, 2018 -31.13%
June 30, 2018 -79.60%
March 31, 2018 -82.16%
December 31, 2017 -81.27%
September 30, 2017 -111.1%
June 30, 2017 -13.35%
March 31, 2017 -20.09%
December 31, 2016 -5.51%
September 30, 2016 -9.58%
June 30, 2016 -5.58%
March 31, 2016 -25.00%
December 31, 2015 -17.00%
September 30, 2015 -20.29%
June 30, 2015 -20.58%
March 31, 2015 -14.30%
December 31, 2014 -69.51%
September 30, 2014 -40.28%
June 30, 2014 3.61%
March 31, 2014 -151.4%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.07%
AngioDynamics, Inc. -8.77%
Alphatec Holdings, Inc. -12.07%
AtriCure, Inc. 5.83%
Baxter International, Inc. 10.01%